E.AlmeK.et al
The AI-powered system can quickly analyze your condition, provide evidence-based recommendations, and connect you with doctors for further evaluation if needed
Currently, there are ten classes of orally available pharmacological agents to treat T2DM: 1) sulfonylureas (SU), 2) meglitinides, 3) metformin (a biguanide), 4) thiazolidinediones (TZDs), 5) alpha glucosidase inhibitors, 6) dipeptidyl peptidase IV (DPP-4) inhibitors, 7) bile acid sequestrants, 8) dopamine agonists, 9) sodium-glucose transport protein 2 (SGLT2) inhibitors and 10) oral glucagon like peptide 1 (GLP-1) receptor agonists (6-8)
Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features
They respond to stress, microbes, and injury by releasing chemical messengers to trigger inflammation and healing
According to the Summary of Product Characteristics (SmPC), the most commonly reported adverse effects include nausea (12-24%), vomiting (2-10%), diarrhoea (13-17%), constipation (6-11%), and abdominal pain (6-10%), with frequencies varying by dose